𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Melatonin in Parkinson’s disease

✍ Scribed by C. A. M. Medeiros; P. F. Carvalhedo de Bruin; L. A. Lopes; M. C. Magalhães; M. de Lourdes Seabra; V. M. Sales de Bruin

Publisher
Springer
Year
2008
Tongue
English
Weight
106 KB
Volume
255
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Melatonin treatment potentiates neurodeg
Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model
✍ Victor Tapias; Jason R. Cannon; J. Timothy Greenamyre 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 400 KB

## Abstract Parkinson's disease (PD) is characterized pathologically by progressive neurodegeneration of the nigrostriatal dopamine (DA) system. Currently, the cause of the disease is unknown, except for a small percentage of familial cases (<10% of total). The rat rotenone model reproduces many of

Visual symptoms in Parkinson's disease a
Visual symptoms in Parkinson's disease and Parkinson's disease dementia
✍ Neil K. Archibald; Mike P. Clarke; Urs P. Mosimann; David J. Burn 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

## Abstract Visual symptoms are common in PD and PD dementia and include difficulty reading, double vision, illusions, feelings of presence and passage, and complex visual hallucinations. Despite the established prognostic implications of complex visual hallucinations, the interaction between cogni